Skip to main content
  1. Market Insights
  2. Health
  3. Pharmaceuticals
  4. Vaccines

Other Vaccines - GCC

GCC
  • The Other Vaccines market in the GCC is forecasted to achieve a revenue of US$437.60m in 2024.
  • With an anticipated annual growth rate (CAGR 2024-2029) of 10.43%, the market is expected to expand and reach a volume of US$718.70m by 2029.
  • In a global context, United States is projected to generate the highest revenue, amounting to US$24.73bn in 2024.
  • The GCC countries are experiencing an increasing demand for other vaccines driven by a growing focus on public health and preventive measures.

Definition:
This market covers all vaccines with the exception of COVID-19 vaccines. Vaccines against infectious diseases transmitted by viruses (e.g., hepatitis A and B) and bacteria (e.g., typhoid fever or meningococcus) are included.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Pfizer, GlaxoSmithKline, Merck & Co, Sanofi

In-Scope

  • Vaccines against infectious diseases
  • Prophylactic and theurapeutic vaccines
  • Flu vaccines

Out-Of-Scope

  • Sera and gammaglobulins
  • Antivirals
  • Antibiotics
  • COVID-19 vaccines
Pharmaceuticals: market data & analysis - Cover

Market Insights report

Pharmaceuticals: market data & analysis

Study Details

    Revenue

    Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.

    Most recent update: Mar 2024

    Analyst Opinion

    The demand for vaccines has been increasing globally, and the GCC region is no exception. The Other Vaccines market in GCC has been witnessing growth due to various factors.

    Customer preferences:
    Customers in the GCC region have been showing an increasing interest in vaccines due to the rise in infectious diseases. The awareness of the importance of vaccination has also been increasing, leading to an increase in demand for vaccines.

    Trends in the market:
    The Other Vaccines market in GCC has been growing at a steady pace due to the increasing demand for vaccines. The market has been witnessing a shift towards combination vaccines, which offer protection against multiple diseases. This trend has been driven by the need to reduce the number of injections required and increase patient compliance. The market has also been witnessing the introduction of new vaccines, which offer protection against emerging diseases.

    Local special circumstances:
    The GCC region has been witnessing an increase in the prevalence of infectious diseases, which has been driving the demand for vaccines. The region has also been witnessing a rise in the number of expatriates, who are more likely to get vaccinated due to the requirements of their home countries. The governments in the region have been actively promoting vaccination programs, which has also been driving the demand for vaccines.

    Underlying macroeconomic factors:
    The GCC region has been experiencing economic growth, which has led to an increase in healthcare spending. The governments in the region have been investing heavily in healthcare infrastructure, which has led to an increase in the availability of vaccines. The region has also been witnessing an increase in medical tourism, which has been driving the demand for vaccines.In conclusion, the Other Vaccines market in GCC has been witnessing growth due to the increasing demand for vaccines, the shift towards combination vaccines, the introduction of new vaccines, the rise in the prevalence of infectious diseases, the increase in the number of expatriates, the promotion of vaccination programs by governments, the economic growth, the investment in healthcare infrastructure, and the increase in medical tourism.

    Global Comparison

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Methodology

    Data coverage:

    Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

    Modeling approach / Market size:

    Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

    Forecasts:

    In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

    Additional notes:

    Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

    Health

    Access more Market Insights on Health topics with our featured report

    Pharmaceuticals: market data & analysis - BackgroundPharmaceuticals: market data & analysis - Cover

    Key Market Indicators

    Notes: Based on data from IMF, World Bank, UN and Eurostat

    Most recent update: Sep 2024

    Source: Statista Market Insights

    Explore more high-quality data on related topic

    Global pharmaceutical industry - statistics & facts

    The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.
    More data on the topic

    Contact

    Get in touch with us. We are happy to help.